MOSCOW (Reuters) – Russia’s Sputnik V vaccine has demonstrated 97.2% efficacy against COVID-19 during the vaccination campaign in Belarus, Russia’s RDIF sovereign wealth fund said on Wednesday.
The Russian Direct Investment Fund is marketing the two-shot vaccine abroad.
(Reporting by Maria Kiselyova; writing by Tom Balmforth; editing by Gabrielle Tétrault-Farber)
